MAPT and early-onset autosomal dominant Alzheimer disease: Following the successful identification of the CSF biomarkers t-tau, p-tau, and Aβ42 that support the clinical diagnosis of Alzheimer’s disease, there has been a growing interest in the discovery of similarly specific CSF biomarkers for PD and AP.